Results 31 to 40 of about 5,873 (176)

Ultra-Long-Term Therapy of Benign Essential Blepharospasm with Botulinumtoxin A—30 Years of Experience in a Tertiary Care Center

open access: yesToxins, 2022
Aim of this study was to investigate the long-term results of botulinum toxin A (BoNT-A) injections for the treatment of benign essential blepharospasm (BEB) and to report our experience with (ultra-)long-term treatment with onabotulinumtoxin-A.
Bettina Wabbels   +2 more
doaj   +1 more source

Flanker Task Performance in Isolated Dystonia (Blepharospasm): A Focus on Sequential Effects

open access: yesBrain Sciences, 2020
Isolated dystonia manifests with involuntary muscle hyperactivity, but the extent of cognitive impairment remains controversial. We examined the executive functions in blepharospasm while accounting for motor symptom-related distractions as a factor ...
Max Pekrul   +4 more
doaj   +1 more source

Exocrine Gland Dysfunction in Parkinson's Disease: Pathophysiology, Clinical Manifestations, and Therapeutic Perspectives—A Narrative Review

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Non‐motor symptoms, especially autonomic dysfunction, are major contributors to disability and decreased quality of life in Parkinson's disease (PD). Despite being common and having a wide range of clinical facets, exocrine gland dysfunction is still not well recognized and managed.
Renato P. Munhoz   +2 more
wiley   +1 more source

Isolated focal dystonia phenotypes are associated with distinct patterns of altered microstructure

open access: yesNeuroImage: Clinical, 2018
Objective: Isolated adult-onset focal dystonia is considered a network disorder with disturbances to the motor basal ganglia and cerebellar circuits playing a pathophysiological role, but why specific body regions become affected remains unknown.
Brian D. Berman   +4 more
doaj   +1 more source

Orofacial Drinking Tremor: A Case Series and Literature Review

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Task‐specific orofacial tremor is a rare condition in which rhythmic oscillations of orofacial muscles occur during specific actions. Drinking tremor represents a recurrent pattern in isolated reports, although its phenomenology and underlying mechanisms remain incompletely defined.
Daniele Birreci   +7 more
wiley   +1 more source

Voxel-Mirrored Homotopic Connectivity of Resting-State Functional Magnetic Resonance Imaging in Blepharospasm

open access: yesFrontiers in Psychology, 2018
Objective: Several networks in human brain are involved in the development of blepharospasm. However, the underlying mechanisms for this disease are poorly understood. A voxel-mirrored homotopic connectivity (VMHC) method was used to quantify the changes
Jing Wei   +11 more
doaj   +1 more source

Personality and psychopathological profile of patients and botulinum therapy for blepharospasm

open access: yesConsilium Medicum, 2023
Background. Blepharospasm (BS) includes non-motor symptoms manifested by psychopathological disorders. The impact of these disorders on patients' quality of life and therapy of motor symptoms with botulinum toxin is poorly understood. Aim.
Violetta A. Tolmacheva   +3 more
doaj   +1 more source

Orbicularis oculi myectomy as a treatment for blepharospasm in a case of Schwartz Jampel syndrome

open access: yesJournal of Ophthalmic & Vision Research, 2016
Purpose: To describe a patient with Schwartz Jampel vel Aberfeld syndrome (SJS) who underwent orbicularis oculi myectomy as a treatment for blepharospasm.
Bahram Eshraghi   +3 more
doaj   +1 more source

A case report of Meige syndrome-like blepharospasm caused by ingestion of allopurinol

open access: yesPakistan Journal of Pharmaceutical Sciences, 2020
One case of allopurinol-caused rare adverse reactions was reported. One male 51-year-old patient presented blurred vision, streaming eyes, photophobia and blepharospasm sequentially 1 week after oral administration of allopurinol.
P.R. China
doaj   +1 more source

Real‐World Patterns of Botulinum Toxin Treatment in Hyperkinetic Movement Disorders: A 9‐Year Nationwide Analysis in France

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Hyperkinetic movement disorders, including dystonia, tremor, and myoclonus, are disabling conditions often managed with botulinum toxin type A (BoNT‐A). Real‐world evidence on treatment patterns remains limited. Objective This nationwide, population‐based study aimed to evaluate trends in BoNT‐A use in France between 2015 and 2023 ...
Marion Simonetta‐Moreau   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy